BioSpace News Archive

Endomimetics announced the awarding of a $292 thousand, one-year National Institute of Health / Small Business Innovation Research grant to support research to develop and evaluate the potential of a BionanomatrixTM formulation to reduce infectious and inflammatory complications that occur following knee arthroplasty.

Ceapro Inc. announced the signing of a technical collaboration with Austria-based NATEX Prozesstechnologie GmbH to accelerate the scale-up of its proprietary PGX Technology towards commercial level.

BioSig Technologies, Inc., a medical technology company committed to delivering unprecedented accuracy and precision to intracardiac signal visualization, announced the appointment of Frederick Hrkac to the new role of Executive Vice President, effective as of November 2, 2023.

Replimune Group, Inc. announced financial results for the fiscal second quarter ended September 30, 2023 and provided a business update.

Aligos Therapeutics, Inc. today announced that the company is presenting six posters at the American Association for the Study of Liver Diseases’ (AASLD) The Liver Meeting® 2023, taking place in Boston, Massachusetts, November 10 – 14, 2023.

UroGen Pharma Ltd. today announced that it will report third quarter 2023 financial results on November 14, 2023, at 8:00 AM EDT, prior to the open of the market.

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present company overviews at the following conferences.

ENB Therapeutics, Inc. today announced top-line results from the dual combination arm of the Phase 1b ENBOLDEN-101 study, evaluating ENB-003 in combination with Merck’s anti-PD-1 therapy KEYTRUDA® (pembrolizumab) in patients with advanced refractory cancers.

Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked the number one large employer in BioSpace’s 2024 Best Places to Work report for the third consecutive year.

Myrtelle Inc. today announced that Christopher Janson , M.D. will deliver a presentation entitled “Translation of Gene Therapy Brain Biomarkers from Nonclinical Science to Clinical Trials: A Case Study in Canavan Disease” on Tuesday, November 7, 2023, at the 5th Annual Gene Therapy for Neurological Disorders Summit in Boston, Massachusetts.